Can a patient with fungal vaginitis deliver vaginally?

　　Vulvovaginal candidiasis (VVC), commonly referred to as “fungal vaginitis,” is generally compatible with vaginal delivery if the condition is well-controlled. However, vaginal delivery is typically not recommended if the infection remains uncontrolled. Should any discomfort arise, prompt medical consultation is advised.

　　Vulvovaginal candidiasis is an inflammatory condition of the vulva and vagina caused by Candida species, primarily presenting with symptoms such as pruritus, burning pain in the vulva, and increased vaginal discharge. Whether vaginal delivery is feasible depends on the individual clinical scenario. In mild cases, timely and standardized antifungal treatment can effectively suppress Candida colonization, restore a healthy vaginal microenvironment, and—provided fetal status remains favorable and maternal pelvic anatomy is normal—vaginal delivery is usually possible.

　　Conversely, in severe or inadequately treated VVC, where large numbers of Candida organisms persist and active inflammation is present, vaginal delivery is generally contraindicated. Attempting vaginal delivery under such circumstances may exacerbate vaginal wall congestion and edema, increasing the risk of perineal lacerations during childbirth. Moreover, passage of the fetus through the infected birth canal may expose the newborn to high concentrations of Candida, raising the risk of neonatal oral thrush or cutaneous candidiasis. In such cases, cesarean delivery is typically recommended to minimize the risk of maternal and neonatal infection.

　　We recommend proactive treatment to control inflammation. Additionally, maintaining healthy lifestyle habits is essential: avoid excessive fatigue and strenuous physical activity, both of which may precipitate or worsen symptoms.